NL-OMON21005已完成不适用
A pilot, open-label, multi-centre study to investigate the safety of Calf Intestinal Alkaline Phosphatase in patients with fulminant active ulcerative colitis refractory to steroid therapy.
AM-Pharma B.V.Rumpsterweg 63981 AK BunnikTHE NETHERLANDSTelephone: +31 (0)30 228 9 222Telefax: +31 (0)30 228 9 2200 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients between 18 and 70 years (inclusive) of age;
- •2. A diagnosis of UC verified by colonoscopy and confirmed by histology;
排除标准
- •1. UC requiring immediate surgical, endoscopic, or radiological interventions, including massive hemorrhage, perforation and sepsis, suppurative complications (intra-abdominal or peri-anal abscesses) or toxic colon;
- •2. History of large bowel surgery;
研究者
相似试验
已完成
不适用
Pilot Prospective CGM Quality Improvement (QI) Project in PregnancyDiabetes Mellitus, Type INCT02556554University of Colorado, Denver67
招募中
不适用
Onderzoek naar de werkzaamheid van toevoeging van Cetuximab aan de combinatie van radiotherapie en Cisplatin bij patiënten met niet-kleincellig longkanker.Cetuximab, non-small lung carcinoma, cisplation, radiotherapy, locally advancedNL-OMON21439KI-AV110
已完成
不适用
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic functiopharmacokinetic of panobinostat in various degrees of hepatic function10027655NL-OMON34474ovartis3
已完成
1 期
The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying CauseCovid19Acute Respiratory Distress SyndromeNCT04537351Cynata Therapeutics Limited14
已完成
1 期
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS)Angelman SyndromeNCT04428281Hoffmann-La Roche74